Management of Polydrug-Resistant Tuberculosis

Background and Objectives: There is a lack of information regarding the effective duration of treatment necessary to prevent the development of acquired resistance when fluoroquinolones (FQ), and/or pyrazinamide (Z) resistance has occurred in patients with polydrug-resistant tuberculosis and isoniaz...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortakoylu, Mediha Gonenc, Kibar Akilli, Isil, Kilic, Lutfiye, Akbaba Bagci, Belma, Akalin, Esma Seda, Aksan, Arzu Deniz, Toprak, Sezer, Mirsaeidi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967441/
https://www.ncbi.nlm.nih.gov/pubmed/36837448
http://dx.doi.org/10.3390/medicina59020246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967441/
https://www.ncbi.nlm.nih.gov/pubmed/36837448
http://dx.doi.org/10.3390/medicina59020246

Ejemplares similares